Inflammatory markers and Type 2 diabetes mellitus as prognostic risk factors in <scp>low‐risk</scp> bladder cancer-Reference-Cited by-同舟云学术

Inflammatory markers and Type 2 diabetes mellitus as prognostic risk factors in low‐risk bladder cancer

Published:2023-04-23 Issue:2 Volume:132 Page:154-156
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU International

Author:

Frego Nicola¹²,Contieri Roberto¹²,Diana Pietro¹²,Mancon Stefano¹²,Colombo Piergiuseppe³²,Lazzeri Massimo¹^ORCID,Buffi Nicolo Maria¹²,Casale Paolo¹,Hurle Rodolfo¹

Affiliation:

1. Department of Urology IRCCS Humanitas Research Hospital Milan Italy

2. Department of Biomedical Sciences Humanitas University Milan Italy

3. Department of Pathology IRCCS Humanitas Research Hospital Milan Italy

Publisher

Wiley

Subject

Urology

Reference9 articles.

1. European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

2. Risk Stratification Tools and Prognostic Models in Non–muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel

3. Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer

4. Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer

5. Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Metabolic Footprint of Systemic Effects in the Blood Caused by Radiotherapy and Inflammatory Conditions: A Systematic Review;Metabolites;2023-09-09